Pulse Wave Velocity and Phase Difference as Novel Biomarkers

  • Research type

    Research Study

  • Full title

    Investigating Pulse Wave Velocity and Phase Difference as Novel Biomarkers in Neonatal Haemodynamics

  • IRAS ID

    237057

  • Contact name

    Mark Turner

  • Contact email

    mturner@liverpool.ac.uk

  • Sponsor organisation

    University of Liverpool

  • Duration of Study in the UK

    0 years, 2 months, 30 days

  • Research summary

    We are going to study a new method of investigating how blood flows around the body of newborn babies.

    Many factors affect the flow of blood around a baby's body shortly after birth. This can greatly affect the baby's overall development and lead to conditions such as chronic lung disease, abnormal brain development and intestinal damage. Currently, investigations such as echocardiography (ultrasound) of the baby's heart are used to assess the flow of blood out of the heart and through the major vessels, however, this requires expert training, and is not a continuous method of monitoring the patient's situation. Intermittent monitoring is disruptive and can be distressing for parents and can also be detrimental to the developing newborn as temperature changes, noise and sleep disturbance caused by the investigation can further hinder their development. One way to gain useful information without disturbing the baby is to measure Pulse Pulse Wave Velocity. This is a validated method of measuring the flow of blood around the body of adults, however, the evidence in neonates is limited. Using data on the electrical activity of the heart and waveform of the pulse (which are collected during routine care), a specialist computer software can calculate this value as well as an additional value known as the "phase difference". We hypothesise that these values will be able to help identify certain heart problems in the future. However, not enough is currently known about factors affecting these values. These factors include things such as the baby's weight, if they are preterm, or if they are suffering from any other diseases. We hope to compare these new measurements to a number of variables in the hope of better understanding them and hopefully stimulating further research into their use as a clinical monitoring tool for the future.

  • REC name

    North East - Tyne & Wear South Research Ethics Committee

  • REC reference

    18/NE/0058

  • Date of REC Opinion

    15 Feb 2018

  • REC opinion

    Favourable Opinion